Literature DB >> 17393267

Anatomically designed prosthesis without cement for the treatment of osteoarthritis due to developmental dysplasia of the hip: 6- to 13-year follow-up study.

Yoshitada Harada1, Shigeru Mitsuhashi, Chiho Suzuki, Keishi Yamashita, Hitoshi Watanabe, Tohru Akita, Hideshige Moriya.   

Abstract

BACKGROUND: Morphological differences of dysplastic hips exist not only on the acetabular side but also on the femoral side. Therefore, for reconstructing the hip joint of these patients, the shape of the proximal femur is problematic for getting adequate "fit and fill" by cementless stems. The purpose of this study was to investigate the clinical and radiological outcomes of anatomically designed prostheses for the treatment of osteoarthritis due to developmental dysplasia of the hip.
METHODS: A total of 81 consecutive primary cementless total hip arthroplasties using an anatomic hip system were performed in 75 patients (10 men, 65 women). The mean age at the time of the surgery was 59.0 years (range 41-84 years). The average duration of follow-up was 101.4 months (range 72-157 months). Clinical performance was evaluated using the Harris hip score (HHS), and radiographic findings were assessed using the fixation and stability score according to Engh et al.
RESULTS: The average preoperative HHS was 44.5 points, and the most recent average HHS was 87.5 points. Altogether, 66 hips (81%) were deemed excellent (>or=90 points) or good (80-89 points). The mean fixation and stability score was 19.6 +/- 5.2 points. In total, 75 (93%) of the femoral components had bone-ingrown fixation, and 6 (7%) indicated possible ingrowth. There was osteolysis around five femoral components and three acetabular components. No femoral component was revised; however, five cups were revised because of breakage of the polyethylene or massive osteolysis. Dislocation of the hip implant was seen in one hip, but there was no recurrent dislocation. There was no deep infection, deep vein thrombosis, or nerve palsy.
CONCLUSIONS: The anatomic stem showed acceptable clinical and radiological results in cases with mild or moderate subluxation of the hip at the intermediate-term follow-up.

Entities:  

Mesh:

Year:  2007        PMID: 17393267     DOI: 10.1007/s00776-006-1099-5

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  6 in total

1.  The twenty-year survivorship of two CDH stems with different design features.

Authors:  George Digas; George Georgiades; Kalliopi Lampropoulou-Adamidou; George Hartofilakidis
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-10-18

2.  Reconstruction with tibial lengthening for limb length discrepancy in Crowe Type IV developmental dysplasia of hip in adulthood.

Authors:  Tang Liu; Xiangsheng Zhang; Zhihong Li; Wen Zeng
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-02-10

3.  Shortening subtrochanteric osteotomy and cup placement at true acetabulum in total hip arthroplasty of Crowe III-IV developmental dysplasia: results of midterm follow-up.

Authors:  Alireza Manafi Rasi; Gholamhossein Kazemian; Mohammad Khak; Reza Zarei
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-11-25

4.  Perioperative patient-specific factors-based nomograms predict short-term periprosthetic bone loss after total hip arthroplasty.

Authors:  Guangtao Fu; Mengyuan Li; Yunlian Xue; Qingtian Li; Zhantao Deng; Yuanchen Ma; Qiujian Zheng
Journal:  J Orthop Surg Res       Date:  2020-11-02       Impact factor: 2.359

5.  Cementless total hip replacement: past, present, and future.

Authors:  Harumoto Yamada; Yasuo Yoshihara; Osamu Henmi; Mitsuhiro Morita; Yuichiro Shiromoto; Tomoki Kawano; Arihiko Kanaji; Kennichi Ando; Masato Nakagawa; Naoto Kosaki; Eiichi Fukaya
Journal:  J Orthop Sci       Date:  2009-04-01       Impact factor: 1.601

6.  Fixation of an anatomically designed cementless stem in total hip arthroplasty.

Authors:  Shigeru Nakamura; Noriyuki Arai; Takateru Kobayashi; Takashi Matsushita
Journal:  Adv Orthop       Date:  2012-04-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.